JNJ

J&J to acquire ADC drug developer Ambrx for $2B
BioPharma Dive
Mon, 01/8/24 - 11:35 am
JNJ
Ambrx
M&A
antibody-drug conjugate
JPMHC 2024
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
Why J&J rebranded its iconic logo
Pharma Voice
Wed, 01/3/24 - 09:43 am
rebranding
logos
JNJ
Medtech's Biggest Winners in 2023
Medical Devices and Diagnostics Industry
Thu, 12/21/23 - 11:35 am
Medtech
CGMs
device manufacturing
JNJ
Medtronic
robotic surgery
Why heart device makers are investing in left atrial appendage closure
Medtech Dive
Wed, 12/13/23 - 09:54 am
Medtech
left atrial appendage closure
atrial fibrillation
stroke
Boston Scientific
JNJ
Medtronic
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Fierce Pharma
Wed, 12/13/23 - 09:45 am
ASH 2023
JNJ
Sanofi
Darzalex
Sarclisa
Multiple Myeloma
ASH23: Pharma branding, Editas’ high bar and clinical trial diversity
BioPharma Dive
Mon, 12/11/23 - 10:52 pm
ASH 2023
JNJ
Editas Medicine
cliincal trials
As ICER places a spotlight on pharma's price hikes, J&J, Roche and more hit back
Fierce Pharma
Mon, 12/11/23 - 10:48 pm
ICER
JNJ
Roche
drug pricing
As J&J outlines bullish pipeline goals, neuroscience pipeline takes a starring role
Fierce Biotech
Wed, 12/6/23 - 09:15 pm
JNJ
Neuroscience
Spravato
major depressive disorder
Johnson & Johnson forecasts as much as 6% sales growth in 2024
Reuters
Tue, 12/5/23 - 10:02 am
JNJ
J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery
BioSpace
Mon, 12/4/23 - 09:40 am
JNJ
artificial intelligence
drug discovery
Bay Area
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey
Fierce Pharma
Sun, 12/3/23 - 09:36 pm
JNJ
AbbVie
Sanofi
Turkey
competition
3 medtech spinoffs that reshaped the industry in 2023, and what to expect next
Medtech Dive
Fri, 12/1/23 - 09:38 am
Medtech
spinoffs
GE Healthcare
JNJ
Danaher
Baxter
3M
Medtronic
J&J Becomes the Newest Player in the LAA Market
Medical Devices and Diagnostics Industry
Thu, 11/30/23 - 11:21 pm
JNJ
M&A
Medtech
Penditure LAA
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Thu, 11/30/23 - 11:20 pm
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
J&J Sheds Light on Plans for Surgical Robot
Medical Devices and Diagnostics Industry
Wed, 11/29/23 - 11:53 am
JNJ
Medtronic
Intuitive Surgical
robotic surgery
Medtech
J&J Seeks Expanded Use of Lung Cancer Drug Rybrevant
Yahoo/Zacks.com
Wed, 11/22/23 - 11:38 am
JNJ
Rybevant
non-small cell lung cancer
AstraZeneca
Tagrisso
Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?
Motley Fool
Fri, 11/17/23 - 09:59 am
JNJ
Intuitive Surgical
Medtech
robotic surgery
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Astellas
Propella Therapeutics
M&A
JNJ
Zytiga
prostate cancer
J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses
Fierce Pharma
Tue, 11/14/23 - 09:56 pm
JNJ
Bayer
Xarelto
blood thinners
AHA
peripheral artery disease

Pages